Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1979-5-24
|
pubmed:abstractText |
Twenty-five children with generalized histiocytosis X were treated with a combination of cyclophosphamide, vinblastine, and prednisone: 8 patients experienced complete response, 8 partial response, 2 imporvement, and 7 no response. Response rates for children over 1 year of age were higher than those reported for single agents. Twelve children are now off therapy with no evidence of disease for 10--50 months. Very poor response rates and high toxicity were seen in children less than 1 year of age. The two infants who eventually achieved CR did so by other therapies. Further trials in combination chemotherapy must weight possible long-term effects of such therapy against the prospect of more rapid disease control.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0098-1532
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
267-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:311409-Administration, Oral,
pubmed-meshheading:311409-Child,
pubmed-meshheading:311409-Child, Preschool,
pubmed-meshheading:311409-Cyclophosphamide,
pubmed-meshheading:311409-Drug Evaluation,
pubmed-meshheading:311409-Drug Therapy, Combination,
pubmed-meshheading:311409-Histiocytosis, Langerhans-Cell,
pubmed-meshheading:311409-Humans,
pubmed-meshheading:311409-Infant,
pubmed-meshheading:311409-Injections, Intravenous,
pubmed-meshheading:311409-Prednisone,
pubmed-meshheading:311409-Time Factors,
pubmed-meshheading:311409-Vinblastine
|
pubmed:year |
1977
|
pubmed:articleTitle |
Combination chemotherapy in histiocytosis X.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|